Skip to main content
Roger Macklis, MD, Radiation Oncology, Cleveland, OH, University Hospitals Cleveland Medical Center

RogerMMacklisMD

Radiation Oncology Cleveland, OH

Breast Cancer, Hematologic Malignancies, Ocular Radiation Oncology

Clinical Professor of Radiation Oncology, University Hospitals Cleveland Medical Center

Dr. Macklis is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Macklis' full profile

Already have an account?

Education & Training

  • Brigham and Women's Hospital/Joint Center for Radiation Therapy
    Brigham and Women's Hospital/Joint Center for Radiation TherapyResidency, Radiation Oncology, 1984 - 1987
  • Dana-Farber Cancer Institute
    Dana-Farber Cancer InstitutePost-Doctoral Fellowship, Radiation Immunology, 1985 - 1986
  • Brigham and Women's Hospital
    Brigham and Women's HospitalInternship, Internal Medicine, 1983 - 1984
  • Harvard Medical School
    Harvard Medical SchoolClass of 1982
  • Yale University
    Yale UniversityBS, Molecular Biophysics, summa cum laude, 1978
  • Yale University
    Yale UniversityMS, Molecular Biophysics, summa cum laude, 1978
  • Yale University
    Yale UniversityB.S., Molecular Biophysics, Summa Cum Laude, 1978
  • Yale University
    Yale UniversityM.S., Molecular Biophysics, Summa Cum Laude, 1978

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 1993 - 2024
  • NY State Medical License
    NY State Medical License 2001 - 2023
  • KY State Medical License
    KY State Medical License 2017 - 2021
  • CA State Medical License
    CA State Medical License 2003 - 2021
  • MN State Medical License
    MN State Medical License 2014 - 2020
  • MI State Medical License
    MI State Medical License 2001 - 2018
  • MA State Medical License
    MA State Medical License 1984 - 2012
  • American Board of Radiology Radiation Oncology
  • Join now to see all

Awards, Honors, & Recognition

  • Who's Who in America 1998
  • Who’s Who in the World 1998
  • Best Doctors in America 1998
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Radium-223 in the Treatment of Osteoblastic Metastases: A Criticial Clinical Review  
    Humm JL. Sartor O. Parker C. Bruland O. and Macklis RM, Int.J Rad. Onc.Biol.Phys, 1/1/2015
  • Clinical characteristics of 95 patients with ocular adnexal and uveal lymphoma: Treatment outcomes in extranodal marginal zone subtype  
    Craig A. Portell, Mary E. Aronow, Lisa A. Rybicki, Roger Macklis, Arun D. Singh, John W. Sweetenham, Clinical Lymphoma Myeloma and Leukemia, 1/1/2013
  • An Overview of ‘Accountable Care Organizations’ For Oncology Specialists  
    Anish J Mehta, Roger Macklis, J. Onc Practice, 1/1/2013
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Lectures

  • Long Term Outcomes of Radiation Therapy 
    1/1/2012
  • Alpha Particle Radiobiology for Radium-223 (“Alpharadin”): The Fortuitous “Goldilocks” Effect Observed For Hormone-Resistant Metastatic Prostate Cancer 
    1/1/2012
  • Radiotherapy and Lymphoma: Evolving Role 
    1/1/2011
  • Join now to see all

Other

  • RIT for Non-Hodgkin’s Lymphoma: Taking the Team Approach 
    Thakkar VV, Mackis R, ADVANCE for Imaging and Oncology Administrators
    1/1/2005
  • Getting on Board 
    Mahadevan A, Macklis RM, Videtic GV, et al, ADVANCE for Imaaging and Oncology Administrators
    1/1/2003
  • Feasibility of human/robot cooperation in image-directed radiation oncology 
    Ameduri SA, Newman WS, Weinhous MS, Glosser GD, Macklis RM, Society Photo-Optical Instrumentation Engineers (SPIE) Int’l Technical Group Newsletter
    1/1/1999
  • Join now to see all

Grant Support

  • Animal Models In Immunochelate RadiotherapyNational Cancer Institute1989–1993

Professional Memberships

Hospital Affiliations

Industry Relationships

  • Extensive tech transfer and translational science effort leadership, Multiple organizations collaborating with multiple commercial partners